miRNA and mRNA Profiling Links Connexin Deficiency to Deafness via Early Oxidative Damage in the Mouse Stria Vascularis
Open Access
- 25 January 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
Pathogenic mutations in the non-syndromic hearing loss and deafness 1 (DFNB1) locus are the primary cause of monogenic inheritance for prelingual hearing loss. To unravel molecular pathways involved in etiopathology and look for early degeneration biomarkers, we used a system biology approach to analyze Cx30−/− mice at an early cochlear post-natal developmental stage. These mice are a DFNB1 mouse model with severely reduced expression levels of two connexins in the inner ear, Cx30, and Cx26. Integrated analysis of miRNA and mRNA expression profiles in the cochleae of Cx30−/− mice at post-natal day 5 revealed the overexpression of five miRNAs (miR-34c, miR-29b, miR-29c, miR-141, and miR-181a) linked to apoptosis, oxidative stress, and cochlear degeneration, which have Sirt1 as a common target of transcriptional and/or post-transcriptional regulation. In young adult Cx30−/− mice (3 months of age), these alterations culminated with blood barrier disruption in the Stria vascularis (SV), which is known to have the highest aerobic metabolic rate of all cochlear structures and whose microvascular alterations contribute to age-related degeneration and progressive decline of auditory function. Our experimental validation of selected targets links hearing acquisition failure in Cx30−/− mice, early oxidative stress, and metabolic dysregulation to the activation of the Sirt1–p53 axis. This is the first integrated analysis of miRNA and mRNA in the cochlea of the Cx30−/− mouse model, providing evidence that connexin downregulation determines a miRNA-mediated response which leads to chronic exhaustion of cochlear antioxidant defense mechanisms and consequent SV dysfunction. Our analyses support the notion that connexin dysfunction intervenes early on during development, causing vascular damage later on in life. This study identifies also early miRNA-mediated biomarkers of hearing impairment, either inherited or age related.This publication has 78 references indexed in Scilit:
- Identifying MicroRNAs Involved in Degeneration of the Organ of Corti during Age-Related Hearing LossPLOS ONE, 2013
- Reduced phosphatidylinositol 4,5-bisphosphate synthesis impairs inner ear Ca 2+ signaling and high-frequency hearing acquisitionProceedings of the National Academy of Sciences of the United States of America, 2012
- MicroRNAs in inner ear biology and pathogenesisHearing Research, 2012
- microRNA-34c is a novel target to treat dementiasThe EMBO Journal, 2011
- MicroRNA181a plays a key role in hair cell regeneration in the avian auditory epitheliumNeuroscience Letters, 2011
- The human deafness-associated connexin 30 T5M mutation causes mild hearing loss and reduces biochemical coupling among cochlear non-sensory cells in knock-in miceHuman Molecular Genetics, 2010
- MicroRNA-34a regulation of endothelial senescenceBiochemical and Biophysical Research Communications, 2010
- Coordinated control of connexin 26 and connexin 30 at the regulatory and functional level in the inner earProceedings of the National Academy of Sciences of the United States of America, 2008
- A microRNA component of the p53 tumour suppressor networkNature, 2007
- Connexin30 deficiency causes instrastrial fluid–blood barrier disruption within the cochlear stria vascularisProceedings of the National Academy of Sciences of the United States of America, 2007